ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional Accepts healthy volunteers

A Study to Learn About COVID-19 RNA-Based Variant-Adapted Vaccine Candidate(s) Against SARS-CoV-2 in Participants Ages 12 Through 64 Years Considered at Higher Risk of Severe COVID-19, and Participants Ages ≥65 Years

ClinicalTrials.gov ID: NCT07069309

Public ClinicalTrials.gov record NCT07069309. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 10, 2026, 10:31 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Protocol to Investigate the Safety, Tolerability, and Immunogenicity of BNT162b2 RNA-Based Variant-Adapted Vaccine Candidate(s) Against SARS-CoV-2 in Participants 12 Through 64 Years of Age Considered at Higher Risk of Severe COVID-19, and Participants ≥65 Years of Age

Study identification

NCT ID
NCT07069309
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
BioNTech SE
Industry
Enrollment
760 participants

Conditions and interventions

Interventions

  • BNT162b2 (2025/2026 recommended SARS-CoV-2 strain) Biological

Biological

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 7, 2025
Primary completion
May 4, 2026
Completion
May 4, 2026
Last update posted
Dec 21, 2025

2025 – 2026

United States locations

U.S. sites
19
U.S. states
14
U.S. cities
16
Facility City State ZIP Site status
Diablo Clinical Research, Inc. Walnut Creek California 94598
Clinical Research Consulting Milford Connecticut 06460
GW Vaccine Research Unit Washington D.C. District of Columbia 20037
The GW Medical Faculty Associates Washington D.C. District of Columbia 20037
Indago Research & Health Center, Inc Hialeah Florida 33012
Palm Springs Community Health Center Miami Lakes Florida 33014
East-West Medical Research Institute Honolulu Hawaii 96814
Kentucky Pediatric/ Adult Research Bardstown Kentucky 40004
Bio-Kinetic Clinical Applications, LLC dba QPS-MO Springfield Missouri 65802
Bio-Kinetic Clinical Applications, LLC dba QPS-MO-Screening and Recruitment Center Springfield Missouri 65807
Rochester Clinical Research, LLC Rochester New York 14609
Accellacare - Wilmington Wilmington North Carolina 28401
CTI Clinical Research Center Cincinnati Ohio 45212
Senders Pediatrics South Euclid Ohio 44121
DM Clinical Research - Philadelphia Philadelphia Pennsylvania 19107
DM Clinical Research- Cyfair Houston Texas 77065
J. Lewis Research, Inc. / Foothill Family Clinic Salt Lake City Utah 84109
J. Lewis Research, Inc. / Foothill Family Clinic South Salt Lake City Utah 84121
Charlottesville Medical Research Charlottesville Virginia 22911

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07069309, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 21, 2025 · Synced May 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07069309 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →